Profile
McKesson Headquarters Somerset NJ US
McKesson Corporation, headquartered at 220 Davidson Ave, Somerset, NJ, is a global leader in the healthcare industry, providing comprehensive solutions to healthcare providers, pharmacies, and patients. The company specializes in pharmaceutical distribution, medical products, and healthcare technology services, supporting the delivery of care across hospitals, retail pharmacies, and clinical settings. As a trusted partner in the healthcare ecosystem, McKesson connects providers with essential medications, supplies, and digital tools to improve patient outcomes and operational efficiency.
Notable for its innovation and commitment to advancing healthcare, McKesson’s headquarters reflects the company’s focus on technology and sustainability. The facility emphasizes modern workspaces designed to foster collaboration and innovation, aligning with McKesson’s mission to leverage data analytics and digital health platforms to transform healthcare delivery. Additionally, the company is recognized for its corporate social responsibility initiatives, including community health programs and efforts to reduce environmental impact through sustainable practices. McKesson’s presence in Somerset underscores its role as a pivotal force in shaping the future of healthcare.
Location Reviews
The reviews for McKesson Headquarters highlight persistent operational and customer service issues, with an overall negative sentiment. Multiple users report recurring problems with order processing, including lost or unprocessed orders, lack of accountability from warehouse staff, and delays that force customers to seek alternatives. One reviewer detailed a situation where a warehouse in Rocklin, CA, failed to input a purchase order into the system, leading to shipping delays and financial inconvenience. Other complaints include abrupt account closures without explanation, unresponsive sales representatives, an outdated website, and high staff turnover, which exacerbate inefficiencies and customer frustration. These issues are compounded by reports of corporate mismanagement, with critics accusing the Board of Directors of neglecting fiduciary duties and failing to address systemic chaos within the company.
Additional reviews point to broader concerns, including allegations of corporate negligence, such as a lien placed on a customer’s property without prior orders and threats to cut off pharmacies associated with a physician. While some reviews focus on McKesson Pharmaceuticals, others critique the company’s Medical Surgical division. Notably, no positive aspects are mentioned in the provided reviews, which consistently emphasize incompetence, poor communication, and a lack of accountability. The sentiment reflects deep dissatisfaction among customers and stakeholders, with calls for greater transparency and reform.